Www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 At the Heart of Longevity Cardiovascular Health A good head and a good heart are always a.

Slides:



Advertisements
Similar presentations
Cardiovascular Side Effects of HIV Treatment
Advertisements

Type 2 Diabetes – An Overview
Get to Goal, Achieve Control
Measures of effect: relative risks, odds ratios, risk difference and number needed to treat Giovanni Tripepi, Kitty J. Jager 1, Friedo W. Dekker 1,2, Christoph.
Ministry of Health Oman Integration of Chronic Disease Care in PHC Dr. Ali Jaffer Mohammed Advisor & Director General of Health Affairs.
Slide 1 Healthcare Utilization and Mortality associated with HIV and HCV: How to address the burden of liver disease Susanna Naggie 1,2, Lawrence Park.
Cardiovascular Risk and dyslipidemia
The Burden of Obesity among a National Probability Sample of Veterans Karin Nelson, MD MSHS Assistant Professor Department of Medicine, University of Washington.
The identification of risk factors and diagnosis of coronary heart disease in men and women prior to their first acute myocardial infarction. Barbara P.
Global Health Estimates: Key figures and tables
Paul Muntner, Lisandro D Colantonio, Mary Cushman, David C Goff Jr
Randall M. Zusman, MD Associate Professor of Medicine
What is cholesterol? Cholesterol is a waxy, fatlike substance that is naturally present in cell walls or membranes everywhere in the body. Your body uses.
1 Epidemiologic Measures of Association Saeed Akhtar, PhD Associate Professor, Epidemiology Division of Epidemiology and Biostatistics Aga Khan University,
Opioid-Related Deaths and Mortality Rates by County, Wisconsin Residents Office of Health Informatics and AIDS/HIV and Hepatitis C Program Bureau.
Dr AP McGovern 1,2, Professor S de Lusignan 1, QICKD trial investigators 1 1 Clincal Informatics, Department of Healthcare Management and Policy, University.
HYPERTENSION: AN OVERVIEW Prof Ahmed Mandil, Dr Hafsa Raheel KSU Dept of Family & Community Medicine.
The results of the SHARP trial. SHARP: Rationale Risk of vascular events is high among patients with chronic kidney disease Lack of clear association.
Clinical Trial Results. org Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson’s Disease Renzo Zanettini, M.D.; Angelo Antonini, M.D.;
CV Health: Three Ways to ‘kNOw’
Test B, 100 Subtraction Facts
Aging, Inflammation, and Organ Damage in HIV+ Patients Jean-Pierre Routy, MD Graeme Moyle, MD Bill Powderly, MD Philippe Morlat, MD.
RENAAL Baseline Characteristics (I) Age, years Male, % Female, % Race, % Asian Black Caucasian Hispanic Other Systolic (mmHg) Diastolic (mmHg) BMI (kg/m.
Slide 1 of 22 IAS–USA Victor G. Valcour, MD Professor of Geriatric Medicine University of California San Francisco Emerging Issues in HIV, Aging, and Cognition.
Use of efavirenz is not associated to an increased risk of neurocognitive impairment in HIV-infected patients Pinnetti C 1, Balestra P.
Highlights From the Survey on the Use of Funds Under Title II, Part A
Lipid Management in 2015: Risk & Controversies
Our Vision – Healthier Kansans living in safe and sustainable environments.
The GARFIELD Registry is funded by an unrestricted research grant from Bayer Pharma AG Lessons Beyond Atrial Fibrillation: Focus on.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 How to manage virologic non- responders, non-genotype 1, relapsers IAS 2013, Session: HCV.
The results of the Study of Heart and Renal Protection (SHARP)
The PREVEND Study: Screening for micro-albuminuria
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Sumeet Subherwal, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, Tracy Y. Wang, W. Brian Gibler, E. Magnus Ohman, Matthew T. Roe, Eric D.
Aging with HIV infection Bill Powderly MD School of Medicine and Medical Sciences University College Dublin Ireland.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Abstract: WEABO205. HIV infection was associated with an increased risk of hip fracture,
Cardiovascular Complications of HIV Mark Boyd MD, FRACP The Kirby Institute for infection and immunity in society 7 th IAS Conference Kuala Lumpur, Malaysia.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.
Cardiovascular Disease: Predicting Risk and Monitoring Outcomes Monica R. Shah, MD, FACC NHLBI AIDS Coordinator Conference on Retroviruses and Opportunistic.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
NCD Complications in HIV Patients Esteban Martinez Hospital Clínic University of Barcelona Barcelona SPAIN Washington D.C., USA,
Evaluating depression in type 2 diabetes co- morbidities in Romanian patients - implications for hypertensive patients Vladut Ioana Corina, MA Center for.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
START study: UK-CAB July2015 Community feedback: START study Simon Collins HIV i-Base
on behalf of the INVEST Investigators
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
THE BODY PRO The HIV Resource for Health Care Professionals Copyright © 2009 The HealthCentral Network, Inc. All rights reserved. This activity is jointly.
Slide 1 of 11 From DA Wohl, MD, at New York, NY: May 03, 2012, IAS-USA. IAS–USA David Alain Wohl, MD Associate Professor of Medicine The University of.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
Factors associated with Mortality in the Study of Fat Redistribution and Metabolic Change in HIV infection Leslie Modrich 1, Rebecca Scherzer 1,2, Andrew.
Using Healthy Heart Data by Rick Frey, PhD Toiyabe Indian Health Project, Inc. A collection of PowerPoint slides that have been used in grant applications,
Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.
The role of treatment versus disease in causing premature non-AIDS morbidity Judith S. Currier, MD University of California, Los Angeles.
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
Carotid Disease – Stent vs Surgery vs Medical Therapy? Mehdi H. Shishehbor, DO, MPH, PhD Director, Endovascular Services Interventional Cardiology & Vascular.
Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
Dr John Cox Diabetes in Primary Care Conference Cork
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Title Ugandan Non-Communicable Diseases and Aging Cohort Study (NCT )
with type 2 diabetes without heart failure?
DYSLIPIDEMIA AND ATHEROSCLEROSIS
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Patterns, predictors, and consequences of non-medical use prescription opioids in the Veterans Aging Cohort Study Brandon DL Marshall, PhD Manning Assistant.
Presentation transcript:

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 At the Heart of Longevity Cardiovascular Health A good head and a good heart are always a formidable combination Nelson Mandela Founder of The Elders ( Peter Reiss Director HIV Monitoring Foundation Professor of Medicine Department of Global Health &Division of Infectious Diseases Amsterdam Institute for Global Health and Development Academic Medical Center, University of Amsterdam

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Disclosures Unrestricted scientific grant support to my insitution for investigator-initiated research fromGilead Sciences, ViiV, Janssen Pharmaceutica, Merck and Bristol Myers Squibb Honoraria paid to my institution for DSMB participation and scientific advisory board participation from Janssen Pharmaceutica and Gilead Sciences

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Case 52 year old man known with HIV for > 15 years. HIV well controlled with cART for 10+ years; CD4 450/mm 3 ART: history of long-term d4T use; currently on TDF+3TC+EFV BMI 27 kg/m 2 ; BP 150/100 mmHg; creatinine clearance 55 ml/min Presents with increasingly frequent episodes of chest pain Evaluation: D x : angina pectoris as result of coronary artery disease

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 What may be contributing to this mans coronary artery disease? 1.Being overweight 2.His HIV infection 3.His hypertension 4.His prior d4T use 5.His reduced renal function 6.Each of the above

Age-related chronic diseases rise exponentially with age Age INCIDENCE Age is the largest single risk factor

Chronic liver disease Neurocognitive decline Non-Aids cancers Chronic kidney disease Osteoporosis & Fragility fractures Cardiovascular disease Frailty Diabetes mellitus Chronic obstructive pulmonary disease

Comorbidity in relation to age

Comorbidity distribution *

Increased age-related complications on ART Frieberg et al., JAMA Internal Med 2013 Increased risk of AMI in HIV compared to HIV uninfected HR = 1.48 (CI = 1.27 – 1.72) Further increase HR if CD4 500 Mean AMI events per 1000 person years N=82,459; Veterans Ageing Cohort Study Virtual Cohort

More Co-morbidity related to worse QoL

Proportion reporting to be 100% unfit-to-work by age category among working age cohort participants I. Stolte et. al. NCHIV 2012; Poster 46 HIV-positivity, older age and experiencing 3 age-associated non-communicable co-morbidities, each were independently associated with higher levels of non-participation in paid work

13 HIV Infection is an Independent Risk Factor for Atherosclerosis Similar in Magnitude to Traditional Cardiovascular Disease Risk Factors Carl Grunfeld, J.A.C. Delaney, Christine Wanke, Judith Currier, Rebecca Scherzer, Mary Lou Biggs, Stephen Sidney, Joseph Polak, Daniel O'Leary, and Richard Kronmal for the FRAM Investigators Funding from the NHLBI, NIH and Department of Veterans Affairs O-114

14 Multivariable Analysis of Associated Factors Estimated Effect in mm Internal CarotidCommon Carotid HIV infection0.15 mm**0.033 mm * Male 0.13 mm***0.054 mm*** Current smoker0.17 mm***0.020 mm** Past smoker0.09 mm***0.020 mm*** Diabetes0.12 mm***0.026 mm*** Age (per 10 years) 0.16 mm***0.073 mm*** Systolic BP (per 10 mmHg) 0.05 mm***0.025 mm*** Diastolic BP (per 10 mmHg) mm*** mm*** Total Chol (per 10 mg/dl) mm***0.004 mm*** HDL (per 10 mg/dl) mm*** mm*** *p<0.01, **p<.001, ***p<.0001; There was a significant gender interaction

Increased risk of cardiovascular disease (CVD) with age in men: a comparison of D:A:D with HIV negative CVD risk equations K. Petoumenos, W. El-Sadr, A dArminio Monforte, C. Sabin, P. Reiss, L. Ryom, S. De Wit, M. Rickenbach, JD Lundgren and M G Law for the D:A:D Study group

Relative risk of CHD from age 40 years

Chronic disease drivers, known and suspected Many chronic diseases of ageing are more common in those with HIV, even after adjustment for ART use and lifestyle factors ART Toxicity Lifestyle (smoking etc.) Clinical Chronic Co-morbidity Persistent Inflammation in treated HIV disease Deeks SG, et al. BMJ 2009; 338:a3172

Control HIV Axial Image Coronal Image F Representative 18 F- FDG PET Images S.Subramanian et al JAMA 2012;308: and S. Grinspoon CROI 2012

Proportion of deaths attributed to AIDS fell over time Largely explained by increases in CD4+ cell counts Proportion of deaths attributed to non- AIDS causes increased over time non-AIDS ̶ defining malignancies now the leading cause in this category Rate of death attributed to cardiovascular or liver disease declined over time possibly suggesting improved management and care Rate of death attributed to non-AIDS malignancy remained stable over time D:A:D: Changes in Causes of Death Over Time (N = 255) (N = 548) Weber R, C. Smith et al. IAC2012. Abstract THAB % 16% 10% 8% 32% AIDS relatedLiver related CVD relatedNADM Other/unknown 22% 9% 10% 20% 39% AIDS relatedLiver-related CVD relatedNADM Other/unknown

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 What advice would you give to our patient? 1.Loose weight and exercise regularly 2.Stop smoking 3.Discontinue cART 4.Change current cART treatment 5.1. and 2 of the above

Age h IV Study Team Academic Medical Center P. Reiss (PI) F.W. Wit M. van der Valk J. Schouten K. Kooij B.C. Elsenga A. Henderiks Public Health Service Amsterdam M. Prins (co-PI) I.G. Stolte M. Martens J. Berkel S. Moll A. van Roosmalen G.R. Visser HIV Monitoring Foundation F. de Wolf S. Zaheri Y.M. Ruijs L. Gras A. Kesselring Amsterdam Institute of Global Health and Development M. Heidenrijk R. Meester F. Janssen Financial support: The Netherlands Organisation for Health Research and Development (ZonMW) grant nr & Stichting AIDS Fonds grant nr Additional unconditional grants from: Gilead Sciences ViiV Healthcare Janssen Pharmaceuticals Merck & Co Bristol Myers Squibb